Navigation Links
Nemours Center for Childhood Cancer Research Receives Over $1 Million in Grants for Cancer Research in 2008
Date:1/8/2009

ls available for children with cancer in the State of Florida. Currently, there is no Phase I cancer center for children in Florida. As a result, Florida children eligible for such studies must go out of state. In conjunction with the Moffitt Cancer Center, All Children's Hospital and the Florida Sunshine Project, Nemours is opening several studies of experimental cancer treatments that will be available to children in Florida.

Sigrid A. Rajasekaran, PhD, was awarded a four-year $720,000 grant from the American Cancer Society to study the mechanism of increased function of growth factors in cancer cells. Growth factors and their binding partners called receptors are increased in a wide spectrum of human cancers, including bladder cancer, renal carcinoma, lung cancer, and brain tumors such as glioblastoma and childhood tumors such as medulloblastoma. In several tumor types, increased receptor levels correlate with poor prognosis. Therefore, growth factor receptors are a promising target for cancer therapy. There are several ongoing clinical trials in various institutions using inhibitors of various growth factor receptors to stop the growth of cancer cells. The project funded by the American Cancer Society will study the molecular mechanism by which ionic imbalance contributes to growth factor receptor activation in cancer cells. Findings should provide new insights into novel therapeutic approaches to target growth factor receptors in cancer cells.

Robert W. Mason, PhD, was awarded a 2-year $200,000 grant from the Alex's Lemonade Stand Foundation to study a new approach to treat neuroblastoma, a common childhood cancer that is very difficult to treat when discovered in children older than 2 years of age. The treatments that are being used today are the same as those used to treat adult cancers and unfortunately they do not work well. Dr. Masons's laboratory discovered a compound that could destroy neuroblastoma cells without affecting other ra
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Ambulatory Services of America, Inc. Announces Joint Venture with Gulf Coast Cancer Centers
2. Packard Childrens Opens West Coasts Most Advanced Pediatric Surgery Center
3. The Leukemia & Lymphoma Society and The University of Kansas Cancer Center Announce Innovative Partnership to Accelerate Drug Development
4. Neuroactive Bike: America's First And Only Mind-Body Fitness Equipment Used For The Ultimate Brain Fitness Gym Program Launched This Month At Lady Of America Fitness Center
5. ChildRC.com Launches The Child Resource Center
6. Global Med Technologies Software Chosen to Automate Indiana Hospital Transfusion Center
7. First RapidArc Radiotherapy Treatment in Italy Takes Place at Leading Milan Cancer Center
8. Berkshire Medical Center Selects Desktop Alert for Mass Notification Solutions
9. Photo: New Yale University Prevention Research Center Study Finds Flat Belly Diet! Reduced Dangerous Visceral Belly Fat by 33%
10. Dialysis Corporation of America Announces Acquisition of Maryland Dialysis Center
11. Researchers at Columbia University Medical Center link blood sugar to normal cognitive aging
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nemours Center for Childhood Cancer Research Receives Over $1 Million in Grants for Cancer Research in 2008 
Nemours Center for Childhood Cancer Research Receives Over $1 Million in Grants for Cancer Research in 2008
Breaking Medicine Technology:Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Webcast of QIAGEN N V s 28Nasdaq 3A QGEN 29 Second Quarter 2009 Financial Results Call Set for August 11 13355 1Webcast of QIAGEN N V s 28Nasdaq 3A QGEN 29 Second Quarter 2009 Financial Results Call Set for August 11 13355 2VIASPACE Pursuing Renewable Energy Business in Asia 13353 1VIASPACE Pursuing Renewable Energy Business in Asia 13353 2VIASPACE Pursuing Renewable Energy Business in Asia 13353 3Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 1Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 2Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 3Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 4Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 5Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 6